RECENT NEWS

Owlstone Medical has announced the recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1. The trial has been designed to support development of a breath test to address the unmet clinical need for more effective early detection of lung cancer through the screening of high-risk asymptomatic individuals.

Cambridge-based EDX Medical Group is developing a new generation of rapid healthcare tests capable of detecting and characterising a wide range of diseases within minutes. The new, miniaturised tests are expected to enable the identification of up to 10 disease markers simultaneously.

Patients across the country will benefit from a £30 million government investment in innovative medical technology which will help ease pressures on the NHS this winter and could include the expansion of 3D checks that speed up cancer tests and novel logistics solutions such as the use of drones.

Healthcare Innovation Consortium (HIC) – a leading UK-based digital health and social care agency – is launching a new programme aimed at combating antimicrobial resistance (AMR) at Global Health 2023.

An interdisciplinary team led by Cornell University has received a five-year grant from US medical research agency the National Institutes of Health (NIH) to launch a new centre for engineering, testing and commercialising point-of-care diagnostic devices that will have international reach.

The Association for Molecular Pathology (AMP), the global molecular diagnostic professional society, has published a review of the current benefits and challenges to using multiplex PCR panels for the detection of microbial pathogens from gastrointestinal, central nervous system, lower respiratory tract, and joint specimens.

The Nobel Assembly at the Karolinska Institutet has awarded the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

The UK Health Security Agency (UKHSA) has launched the first iteration of its new dashboard, which will serve as a centralised source for infectious disease and outbreak data this winter, making it publicly available in a timely and transparent way.

Labcold, an ISO9001 certified UK specialist manufacturer of medical and scientific refrigeration, will be unveiling a new range of ATEX fridges and freezers to complement its existing range of laboratory cooling products at this year’s Lab Innovations.

A cutting-edge pathology laboratory designed to serve patients across West Yorkshire has been officially opened by the Minister of State for Health and Secondary Care, Will Quince.

Bio-Rad Laboratories has announced the launch of its new PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.

Multiple myeloma diagnostics and monitoring company Sebia, has launched its new serum-based Minimal Residual Disease (MRD) test for monitoring in multiple myeloma. M-inSight is a laboratory developed test being offered by Corgenix (pictured) - a licensed clinical laboratory and part of the Sebia Group.

PCR Biosystems, a leading PCR reagent developer, has launched a new range of Bst polymerase reagents that offer greater sensitivity, speed, and specificity in all isothermal amplification applications.

Curenetics, Queen Mary University London (QMUL), Oracle Cancer Trust and South East Health Technologies Alliance (SEHTA) are working collaboratively to pioneer a transformative approach to oral cancer detection through the Novel AI-Enabled qMIDS Test. This groundbreaking project is poised to elevate precision cancer diagnostics by harnessing the power of artificial intelligence.

Revvity has unveiled its groundbreaking Pin-point base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories.

On the first day of its biennial Congress, the Institute of Biomedical Science (IBMS) has published its Long Term Biomedical Scientist Workforce Plan, presenting a bold strategy for the UK to develop the biomedical scientist workforce to operate at the highest levels of practice through training, experience and professional qualifications.

Tasso has announced its Tasso+ pain-free blood lancet device that collects whole liquid blood samples, has received CE Mark certification.

The British In Vitro Diagnostics Association (BIVDA) has announced the appointment of Helen Dent as its interim Chief Executive Officer.

Are you a laboratory professional looking to expand your skills in laboratory management? The UKAS Training Academy is holding a three-day in-person Laboratory Management course in Maidenhead on 30 October.

Together with 34 national associations, MedTech Europe has sent an open letter to Commissioner for Health, Stella Kyriakides, regarding the need for comprehensive structural reform in the European regulatory framework for medical technologies (IVDR and MDR).